Dr. William Price Rennie, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 201 Manor Pl, Greenport, NY 11944 Phone: 631-477-5466 |
Dr. Kai Maarten Sturmann, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 Manor Place, Emergency Department, Greenport, NY 11944 Phone: 631-477-5144 |
Dr. Mark Fenig, M.D., MPH Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 Manor Pl, Greenport, NY 11944 Phone: 631-477-1000 |
Dr. Ryan J Zapata, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 Manor Pl, Greenport, NY 11944 Phone: 631-477-5427 Fax: 631-477-5822 |
Dr. Desiree Stemberga, MD Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 201 Manor Pl, Greenport, NY 11944 Phone: 631-477-5466 |
Dr. Joseph Carl Sciammarella Jr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 Manor Pl, Greenport, NY 11944 Phone: 631-477-5144 |
Farheen Gaffar, PA-C Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 201 Manor Pl, Greenport, NY 11944 Phone: 631-477-5466 |
News Archive
A fully self-guided treatment using virtual reality is effective in reducing fear of heights. A team of researchers from Vrije Universiteit Amsterdam and the University of Twente, led by Dr. Tara Donker, developed ZeroPhobia (www.zerophobia.app), a treatment delivered through a smartphone app and a basic VR viewer.
Scientists have discovered the first direct evidence that a biological mechanism long suspected in epilepsy is capable of triggering brain seizures – opening the door for studies to seek improved treatments or even preventative therapies.
Lack of sleep could make you fat. In an editorial published in the Jan. 10 issue of the Archives of Internal Medicine, two Northwestern University researchers stress the need to better understand the growing epidemic of obesity in the United States by studying how loss of sleep alters the complex metabolic pathways that control appetite, food intake and energy expenditure.
Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.
› Verified 1 days ago